€107,226
▼ Sales (15 ops.)
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Ali Faraz. Officer active across 1 company, notably Tenaya Therapeutics, Inc.. Aggregated, 19 filings have been logged. Split: 0 buy · 15 sells. Total volume traded: €107k. History available since 15 February 2023. The latest transaction was filed on 17 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Ali Faraz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
5,837 shares@ US$0.7097Common StockSEC:0001193125-26-354518:0
3,969 shares@ US$0.7098Common StockSEC:0001193125-26-354518:1
5,020 shares@ US$0.7097Common StockSEC:0001193125-26-354518:2
7,406 shares@ US$0.7097Common StockSEC:0001193125-26-354518:3
3,390 shares@ US$0.79340.0015% mcap2.8% of flowCommon StockSEC:0001193125-26-231324:0
5,851 shares@ US$0.6433.8% of flowCommon StockSEC:0001193125-26-055442:0
3,979 shares@ US$0.64312.6% of flowCommon StockSEC:0001193125-26-055442:1
5,032 shares@ US$0.6433.3% of flowCommon StockSEC:0001193125-26-055442:2
158,600 shares0Common StockSEC:0001193125-26-039760:0
3,126 shares@ US$1.333.8% of flowCommon StockSEC:0001193125-25-284996:0
5,720 shares@ US$1.2536.8% of flowCommon StockSEC:0001667937-25-000006:0
3,189 shares@ US$0.44271.5% of flowCommon StockSEC:0000950170-25-073823:0
5,794 shares@ US$0.53843.4% of flowCommon StockSEC:0000950170-25-036770:0
107,500 shares0Common StockSEC:0000950170-25-016582:0
5,802 shares@ US$2.894518.2% of flowCommon StockSEC:0000950170-24-098234:0
85,000 shares0Common StockSEC:0000950170-24-021546:0
6,358 shares@ US$5.8641.2% of flowCommon StockSEC:0000950170-24-016664:0
5,563 shares@ US$3.8123.2% of flowCommon StockSEC:0001209191-23-046639:0
125,000 shares0Common StockSEC:0001209191-23-010880:0
About Ali Faraz
Ali Faraz is a declarant associated with Tenaya Therapeutics, Inc., where he is Chief Executive Officer. Across 15 filings in total, the 15 sampled filings from 2023-02-17 to 2026-05-19 show only sales, for a total of EUR 93605 and no purchases.